Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP19A1 | P11511 | 3/20 | 0.51 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.43 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.43 |
| ▸ | GAA | P10253 | 4/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.42 |
| ▸ | HPGD | P15428 | 3/20 | 0.42 |
| ▸ | GLA | P06280 | 1/20 | 0.42 |
| ▸ | RCE1 | Q9Y256 | 1/20 | 0.42 |
| ▸ | CNR1 | P21554 | 3/20 | 0.41 |
| ▸ | MEN1 | O00255 | 2/20 | 0.41 |
| ▸ | MAPT | P10636 | 2/20 | 0.41 |
| ▸ | GABRA1 | P14867 | 2/20 | 0.41 |
| ▸ | CNR2 | P34972 | 2/20 | 0.41 |
| ▸ | GABRB2 | P47870 | 2/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.41 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.41 |
| ▸ | ALDH2 | P05091 | 1/20 | 0.41 |
| ▸ | AKR1B1 | P15121 | 1/20 | 0.41 |
| ▸ | PPARG | P37231 | 1/20 | 0.41 |
| ▸ | PPARD | Q03181 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27878693 | 0.83 | CYP19A1 (0.50) | CYP19A1KDM4EGAAALDH1A1HPGD | |
| SCHEMBL8768626 | 0.81 | CYP19A1 (0.39) | CYP19A1KDM4EL3MBTL1GAAALDH1A1 | |
| SCHEMBL5573402 | 0.81 | ESR2 (0.54) | CYP19A1ALDH1A1MEN1CNR2KMT2A | |
| SCHEMBL7198375 | 0.81 | GABRA1 (0.41) | CYP19A1KDM4EGAAALDH1A1HPGD | |
| SCHEMBL4620939 | 0.81 | GABRA1 (0.41) | CYP19A1KDM4EGAAALDH1A1HPGD | |
| SCHEMBL3910779 | 0.80 | CYP19A1 (0.56) | CYP19A1KDM4EGAAALDH1A1HPGD | |
| SCHEMBL1838707 | 0.79 | CYP19A1 (0.55) | CYP19A1KDM4EL3MBTL1GAAALDH1A1 | |
| SCHEMBL19567997 | 0.79 | CYP19A1 (0.55) | CYP19A1KDM4EL3MBTL1GAAALDH1A1 | |
| SCHEMBL9377731 | 0.79 | CSNK2A1 (0.57) | CYP19A1KDM4EGAAALDH1A1HPGD | |
| SCHEMBL31022184 | 0.79 | CYP19A1 (0.55) | CYP19A1KDM4EL3MBTL1GAAALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7282245-B2 | Device with multiple liquid crystal layers | XEROX CORPORATION (US) | 2007-10-16 | — | — | US | disclosed |
| US-7211301-B2 | Liquid crystal compositions including non-dipolar monomer | XEROX CORPORATION (US) | 2007-05-01 | — | — | US | disclosed |
| US-20060088667-A1 | Device with multiple liquid crystal layers | XEROX CORPORATION | 2006-04-27 | — | — | US | disclosed |
| US-6994801-B2 | Compounds of formula (4) to stabilize liquid crystal domains | XEROX CORPORATION (US) | 2006-02-07 | — | — | US | disclosed |
| EP-1439215-B1 | Domain size controlled liquid crystals | XEROX CORP (US) | 2005-12-14 | — | — | EP | disclosed |
| US-6939478-B2 | Compounds of formula (2) to stabilize liquid crystal domains | XEROX CORPORATION (US) | 2005-09-06 | — | — | US | disclosed |
| US-6905633-B2 | Compounds of formula (3) to stabilize liquid crystal domains | XEROX CORPORATION (US) | 2005-06-14 | — | — | US | disclosed |
| US-6858266-B2 | Mixture with stabilizer; variations in light scattering | XEROX CORPORATION (US) | 2005-02-22 | — | — | US | disclosed |
| US-6849204-B2 | Compounds of formulas (5) and (6) to stabilize liquid crystal domains | XEROX CORPORATION (US) | 2005-02-01 | — | — | US | disclosed |
| US-6824708-B2 | SWITCHABLE BETWEEN STRONGLY AND WEAKLY SCATTERING STATES | XEROX CORPORATION | 2004-11-30 | — | — | US | disclosed |
| US-20040195547-A1 | Compounds of formula (4) to stabilize liquid crystal domains | XEROX CORPORATION | 2004-10-07 | — | — | US | disclosed |
| US-6767480-B2 | CONJUGATED BRIDGED ELECTRON ACCEPTOR AND DONOR MOIETIES | XEROX CORPORATION | 2004-07-27 | — | — | US | disclosed |
| EP-1439215-A1 | Domain size controlled liquid crystals | Xerox Corporation (US) | 2004-07-21 | — | — | EP | disclosed |
| US-20040113121-A1 | COMPOUNDS OF FORMULA (1) TO STABILIZE LIQUID CRYSTAL DOMAINS | XEROX CORPORATION | 2004-06-17 | — | — | US | disclosed |
| US-20040113119-A1 | Compounds of formulas (3) and (4) to stabilize liquid crystal domains | XEROX CORPORATION | 2004-06-17 | — | — | US | disclosed |
| US-20040115367-A1 | Compounds of formula (2) to stabilize liquid crystal domains | XEROX CORPORATION | 2004-06-17 | — | — | US | disclosed |
| US-20040115366-A1 | Domain size controlled liquid crystals | XEROX CORPORATION | 2004-06-17 | — | — | US | disclosed |
| US-20040113123-A1 | Liquid crystal compositions including dispersant | XEROX CORPORATION | 2004-06-17 | — | — | US | disclosed |
| US-20040113122-A1 | Liquid crystal compositions including non-dipolar monomer | XEROX CORPORATION | 2004-06-17 | — | — | US | disclosed |
| US-20040113120-A1 | Compounds of formulas (5) and (6) to stabilize liquid crystal domains | XEROX CORPORATION | 2004-06-17 | — | — | US | disclosed |